How has the biotech industry responded to bacterial foes? What can we learn from the past to help us navigate the present? How has the industry evolved and how are
How has the biotech industry responded to bacterial foes? What can we learn from the past to help us navigate the present? How has the industry evolved and how are we addressing the threat of infectious agents today? How does our new understanding of the human microbiome change how we think about and manage health?
Join moderator Susan Perkins, Curator of Molecular Systematics at the American Museum of Natural History, as she speaks with expert guests about the history and evolution of antibiotics, the ramifications of antibiotic use, and the role that a healthy microbiome plays in health and disease.
- J.C. Gutierrez-Ramos, CEO of Synlogic
- Tim Hunt, former Senior Vice President of Public Affairs at Cubist Pharmaceuticals
- Tom Luby, Senior Director of New Ventures at Johnson & Johnson Innovation
- Bernat Olle, co-founder and CEO of Vedanta Biosciences
- Rene Russo, Chief Development Officer at Arsanis Biosciences
- Susan Perkins (moderator), curator and professor, American Museum of Natural History
Tuesday, April 12, 2016
(Tuesday) 5:30 pm - 9:00 pm
Embassy Suites - Boston Logan Airport
207 Porter Street Boston, Massachusetts 02128